Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome

Abstract

NALP-1 inflammasome proteins are potential biomarkers to assess TBI severity, outcome, and the secondary injury mechanisms impeding recovery, serving as adjuncts to clinical predictors.